Incordex (ICDX) Annual Balance Sheets

Annual · GAAP · USD millions
Access ICDX quarterly Balance Sheets →
The data below summarizes Incordex's balance sheet position from to Jun 30 2024, enabling a period-by-period comparison of financial strength.
Annual Report, GAAP in USD millions
ITEM
(Jun 30 2024)
(Jun 30 2023) (Jun 30 2022) (Jun 30 2021)
Assets
Cash & cash equivalent0.00
Cash & Short-term Investments0.00
Other Current Assets0.00
Total loans net0.00
Total Current Assets0.00
Intangible Assets0.00
Deferred, Prepaid and Other Assets, Noncurrent0.00
Other Assets, Noncurrent0.02
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents0.00
Total Assets0.02
Liabilities
Accounts Payable, Current AC0.01
Other Liabilities, Current0.00
Total Current Liabilities0.01
Total Long-term Debt0.00
Other liabilities, Noncurrent0.02
Due To Related Parties Noncurrent Amount0.02
Total Liabilities0.03
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock0.03
Retained Earnings / Accumulated Deficit-0.04
Other Equity0.00
Common Stockholder's Equity-0.01
Total Stockholder's Equity-0.01
Liabilities & Stockholder's Equity0.02
4 historic quarters locked

Sign in to unlock the full Incordex balance sheet history.

About Incordex Corp Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20240630)
  • Filed with the SEC: September 24, 2024
  • Source: incordex_10k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001477932-24-005890

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.